Form 4: Bio-Rad Laboratories President Reports Stock Transaction
Insider Transaction (Form 4)
Eva Anette Engelhardt, EVP, President, CDG of Bio-Rad Laboratories, Inc., reported multiple transactions in common stock on July 25, 2026.
Summary
- Option exercise/conversion: acquired 246 Bio-Rad A Common Stock on July 25, 2026; holds 592 after (Direct).
- Tax/exercise-price withholding: disposed of 89 Bio-Rad A Common Stock at $314.46 ($27,987) on July 25, 2026; holds 503 after (Direct).
- Option exercise/conversion: disposed of 246 Restricted Stock Units on July 25, 2026; holds 492 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Eva Anette Engelhardt — Officer (EVP, President, CDG)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-25 | Option exercise/conversion | Bio-Rad A Common Stock | 246 | — | — | 592 |
| 2026-07-25 | Tax/exercise-price withholding | Bio-Rad A Common Stock | 89 | $314 | $28.0K | 503 |
| 2026-07-25 | Option exercise/conversion | Restricted Stock Units | 246 | — | — | 492 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-25 | Option exercise/conversion (246 shares) |
| 2026-07-25 | Tax/exercise-price withholding (89 shares) |
| 2026-07-25 | Option exercise/conversion (246 shares) |
Keywords
insider transaction, Form 4, BIO BIO.B, BIO-RAD LABORATORIES, INC., neutral, Eva Anette Engelhardt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.